Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1931195 | 0.94 | TSHR (0.57) | TSHRALDH1A1CYP3A4HTTLMNA | |
| SCHEMBL19873327 | 0.93 | TSHR (0.55) | TSHRALDH1A1CYP3A4HTTLMNA | |
| SCHEMBL19873325 | 0.93 | TSHR (0.55) | TSHRALDH1A1CYP3A4HTTLMNA | |
| Ammonia Solution, Strong SCHEMBL22444382 | 0.93 | TSHR (0.55) | TSHRALDH1A1CYP3A4HTTLMNA | |
| SCHEMBL19873329 | 0.93 | TSHR (0.55) | TSHRALDH1A1CYP3A4HTTLMNA | |
| SCHEMBL909838 | 0.90 | ALDH1A1 (0.60) | TSHRALDH1A1CYP3A4HTTLMNA | |
| SCHEMBL5535017 | 0.85 | ALDH1A1 (0.44) | TSHRALDH1A1CYP3A4HTTLMNA | |
| SCHEMBL6681722 | 0.85 | TSHR (0.55) | TSHRALDH1A1CYP3A4HTTLMNA | |
| SCHEMBL6578547 | 0.85 | TSHR (0.48) | TSHRALDH1A1CYP3A4HTTLMNA | |
| SCHEMBL31299226 | 0.83 | HRH4 (0.50) | TSHRALDH1A1CYP3A4HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6977309-B2 | Compounds having a secondary or tertiary hydroxy of halide group separated from a primary carbamate group by three or more carbon atoms and a method of making the same | BASF CORPORATION (US) | 2005-12-20 | — | — | US | disclosed |
| US-6900270-B2 | Curable coating compositions with carbamate compounds | BASF CORPORATION (US) | 2005-05-31 | — | — | US | disclosed |
| US-6858674-B2 | Carbamate functional materials, a method of making said materials, and curable coating compositions containing said materials | BASF CORPORATION (US) | 2005-02-22 | — | — | US | disclosed |
| US-20040087715-A1 | Carbamate functional materials, a method of making said materials, and curable coating compositions containing said materials | BASF CORPORATION | 2004-05-06 | — | — | US | disclosed |
| US-20040087737-A1 | Curable coating compositions containing reactive compounds having a secondary or tertiary hydroxy or halide group separated from a primary carbamate group by three or more carbon atoms | BASF CORPORATION | 2004-05-06 | — | — | US | disclosed |
| US-20040087738-A1 | Compounds having a secondary or tertiary hydroxy or halide group separated from a primary carbamate group by three or more carbon atoms and a method of making the same | BASF CORPORATION | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087738-A1 | Compounds having a secondary or tertiary hydroxy or halide group separated from a primary carbamate group by three or more carbon atoms and a method of making the same | HCRTR1, HRH4, HCRTR2 | TSHR 258/4885ALDH1A1 2649/4885CYP3A4 378/4885 |
| US-20040087715-A1 | Carbamate functional materials, a method of making said materials, and curable coating compositions containing said materials | CAPG, MGMT, C9 | TSHR 4740/4885ALDH1A1 1560/4885CYP3A4 1908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.